Denali Therapeutics Inc.: Form 8-K, filed Oct 10, 2024
Filed with the SEC on Oct 10, 2024 and accepted by EDGAR at Oct 10, 2024, 16:02 ET.
Items reported
- Item 7.01 Regulation FD disclosure
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001714899-24-000205. Last ingested by Listed: Nov 3, 2026, 19:01 ET. Listed shows no prices and gives no investment advice.